Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
Brignole C, Bensa V, Fonseca NA, Del Zotto G, Bruno S, Cruz AF, Malaguti F, Carlini B, Morandi F, Calarco E, Perri P, Moura V, Emionite L, Cilli M, De Leonardis F, Tondo A, Amoroso L, Conte M, Garaventa A, Sementa AR, Corrias MV, Ponzoni M, Moreira JN, Pastorino F. Brignole C, et al. Among authors: calarco e. J Exp Clin Cancer Res. 2021 Jun 2;40(1):180. doi: 10.1186/s13046-021-01993-9. J Exp Clin Cancer Res. 2021. PMID: 34078433 Free PMC article.
Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M, Bachetti T, Corrias MV, Brignole C, Pastorino F, Calarco E, Bensa V, Giusto E, Ceccherini I, Perri P. Ponzoni M, et al. Among authors: calarco e. J Exp Clin Cancer Res. 2022 Mar 11;41(1):92. doi: 10.1186/s13046-022-02281-w. J Exp Clin Cancer Res. 2022. PMID: 35277192 Free PMC article. Review.
Nucleolin expression has prognostic value in neuroblastoma patients.
Cangelosi D, Brignole C, Bensa V, Tamma R, Malaguti F, Carlini B, Giusto E, Calarco E, Perri P, Ribatti D, Fonseca NA, Moreira JN, Eva A, Amoroso L, Conte M, Garaventa A, Sementa AR, Corrias MV, Ponzoni M, Pastorino F. Cangelosi D, et al. Among authors: calarco e. EBioMedicine. 2022 Nov;85:104300. doi: 10.1016/j.ebiom.2022.104300. Epub 2022 Oct 6. EBioMedicine. 2022. PMID: 36209521 Free PMC article.
Bone Marrow Environment in Metastatic Neuroblastoma.
Brignole C, Pastorino F, Perri P, Amoroso L, Bensa V, Calarco E, Ponzoni M, Corrias MV. Brignole C, et al. Among authors: calarco e. Cancers (Basel). 2021 May 19;13(10):2467. doi: 10.3390/cancers13102467. Cancers (Basel). 2021. PMID: 34069335 Free PMC article. Review.
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models.
Capasso M, Brignole C, Lasorsa VA, Bensa V, Cantalupo S, Sebastiani E, Quattrone A, Ciampi E, Avitabile M, Sementa AR, Mazzocco K, Cafferata B, Gaggero G, Vellone VG, Cilli M, Calarco E, Giusto E, Perri P, Aveic S, Fruci D, Tondo A, Luksch R, Mura R, Rabusin M, De Leonardis F, Cellini M, Coccia P, Iolascon A, Corrias MV, Conte M, Garaventa A, Amoroso L, Ponzoni M, Pastorino F. Capasso M, et al. Among authors: calarco e. J Transl Med. 2024 Feb 13;22(1):151. doi: 10.1186/s12967-024-04954-w. J Transl Med. 2024. PMID: 38351008 Free PMC article.
Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma.
Brignole C, Calarco E, Bensa V, Giusto E, Perri P, Ciampi E, Corrias MV, Astigiano S, Cilli M, Loo D, Bonvini E, Pastorino F, Ponzoni M. Brignole C, et al. Among authors: calarco e. J Immunother Cancer. 2023 Sep;11(9):e007174. doi: 10.1136/jitc-2023-007174. J Immunother Cancer. 2023. PMID: 37775116 Free PMC article.
Achievement of therapeutic targets in Mexican patients with diabetes mellitus.
Lavalle-González FJ, Chiquete E, de la Luz J, Ochoa-Guzmán A, Sánchez-Orozco LV, Godínez-Gutiérrez SA; IDMPS-3W collaborative group (Mexico). Lavalle-González FJ, et al. Endocrinol Nutr. 2012 Dec;59(10):591-8. doi: 10.1016/j.endonu.2012.07.005. Epub 2012 Nov 6. Endocrinol Nutr. 2012. PMID: 23137765